US Patent 9309193 Heterodimers of glutamic acid
Patent 9309193 was granted and assigned to Molecular Insight Pharmaceuticals, Inc. on April, 2016 by the United States Patent and Trademark Office.
Name
# Contributions
Last Contribution
Find more entities like US Patent 9309193 Heterodimers of glutamic acid
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.